A detailed history of Center For Financial Planning, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 170 shares of NVO stock, worth $14,852. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170
Previous 100 70.0%
Holding current value
$14,852
Previous $14,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $8,334 - $10,179
70 Added 70.0%
170 $20,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $4,547 - $9,977
50 Added 100.0%
100 $9,000
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $7,798 - $8,632
50 New
50 $8,000
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $3,923 - $4,628
38 New
38 $4,000
Q2 2020

Aug 06, 2020

SELL
$58.54 - $67.94 $3,102 - $3,600
-53 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $2,642 - $3,087
53 New
53 $3,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Center For Financial Planning, Inc. Portfolio

Follow Center For Financial Planning, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Center For Financial Planning, Inc. with notifications on news.